VRTX — Vertex Pharmaceuticals Incorporated Share News
0.000.00%
Last trade - 00:00- $128.95bn
- $121.10bn
- $12.00bn
Vertex beats quarterly estimates on cystic fibrosis demand, new drugs
Vertex Pharma Q3 revenue beats estimates on strong demand for cystic fibrosis therapies
Brief: Vertex Pharmaceuticals VERTEX PHARMACEUTICALS Q3 ADJUSTED EPS USD 4.8 VS. IBES ESTIMATE USD 4.56
Brief: Vertex Announces Progress In Povetacicept Development Program And Presentation Of New Data At American Society Of Nephrology Kidney Week
US. STOCKS ON THE MOVE-Vertex, IBM, Silver Miners
US. STOCKS ON THE MOVE-Vertex, IBM, silver miners
Vertex climbs after FDA's 'breakthrough therapy' tag for kidney disease drug
Brief: Vertex Announces Key Advancements Across Kidney Portfolio
Brief: Vertex Scientists Awarded The 2025 Lasker~Debakey Clinical Medical Research Award
WHO adds GLP-1 drugs for diabetes, others to essential medicines list
Brief: Enlaza Therapeutics Strategic Collaboration With Vertex Pharmaceuticals To Develop War-Lock Drug Conjugates And T-Cell Engagers
US stocks weekly: Reheat
US stocks weekly: Reheat
Live Markets: Weak data, tariff worries sour Wall Street's mood
U.S. STOCKS ON THE MOVE-Axon, Cummins, Pfizer
U.S. STOCKS ON THE MOVE-Axon, Cummins, Pfizer
Vertex falls after pain drug setback
U.S. STOCKS ON THE MOVE-Caterpillar, Pfizer, Zebra Technologies
U.S. STOCKS ON THE MOVE-Caterpillar, Pfizer, Zebra Technologies